Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells.

Apoptosis Colorectal cancer Fucoxanthin Fucoxanthinol NF-κB

Journal

Genes and environment : the official journal of the Japanese Environmental Mutagen Society
ISSN: 1880-7046
Titre abrégé: Genes Environ
Pays: England
ID NLM: 101285347

Informations de publication

Date de publication:
2019
Historique:
received: 29 10 2018
accepted: 20 12 2018
entrez: 30 1 2019
pubmed: 30 1 2019
medline: 30 1 2019
Statut: epublish

Résumé

Evidence from epidemiological and experimental studies has shown that the etiology of colorectal cancer (CRC) is related to lifestyle, mainly diet. At the same time, there are many foods and beverages that have been shown to provide protection against CRC. We turned our attention to a traditional Japanese food, brown algae, that contains carotenoids and various functional polyphenols, especially fucoxanthin (FX) and fucoxanthinol (FxOH). Both FX and FxOH treatments induced apoptosis in a dose-dependent and time-dependent manner as detected by annexin V / propidium iodide and the presence of a subG1 population in human colon cancer HCT116 cells. This apoptotic effect of FxOH was stronger than that of FX. We also found that nuclear factor-kappa B (NF-κB) transcriptional activity was significantly increased by treatment with ≥5 μM FxOH. Thus, we cotreated the cells with FxOH plus NF-κB inhibitor, and the results demonstrated that this cotreatment strongly enhanced the induction of apoptosis compared with the effects of FxOH or NF-κB inhibitor treatment alone and resulted in X-linked inhibitor of apoptosis (IAP) downregulation. This study suggested that FxOH is a more potent apoptosis-inducing agent than FX and that its induction of apoptosis is enhanced by inhibiting NF-κB transcriptional activity via suppression of IAP family genes.

Sections du résumé

BACKGROUND BACKGROUND
Evidence from epidemiological and experimental studies has shown that the etiology of colorectal cancer (CRC) is related to lifestyle, mainly diet. At the same time, there are many foods and beverages that have been shown to provide protection against CRC. We turned our attention to a traditional Japanese food, brown algae, that contains carotenoids and various functional polyphenols, especially fucoxanthin (FX) and fucoxanthinol (FxOH).
RESULTS RESULTS
Both FX and FxOH treatments induced apoptosis in a dose-dependent and time-dependent manner as detected by annexin V / propidium iodide and the presence of a subG1 population in human colon cancer HCT116 cells. This apoptotic effect of FxOH was stronger than that of FX. We also found that nuclear factor-kappa B (NF-κB) transcriptional activity was significantly increased by treatment with ≥5 μM FxOH. Thus, we cotreated the cells with FxOH plus NF-κB inhibitor, and the results demonstrated that this cotreatment strongly enhanced the induction of apoptosis compared with the effects of FxOH or NF-κB inhibitor treatment alone and resulted in X-linked inhibitor of apoptosis (IAP) downregulation.
CONCLUSIONS CONCLUSIONS
This study suggested that FxOH is a more potent apoptosis-inducing agent than FX and that its induction of apoptosis is enhanced by inhibiting NF-κB transcriptional activity via suppression of IAP family genes.

Identifiants

pubmed: 30693059
doi: 10.1186/s41021-018-0116-1
pii: 116
pmc: PMC6341523
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1

Déclaration de conflit d'intérêts

No animal nor human subjects were used.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Références

Nat Med. 1999 Apr;5(4):412-7
pubmed: 10202930
Cytometry. 1992;13(8):795-808
pubmed: 1333943
Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907
pubmed: 15520809
Biochim Biophys Acta. 2004 Nov 18;1675(1-3):113-9
pubmed: 15535974
Biosci Biotechnol Biochem. 2005 Jan;69(1):224-7
pubmed: 15665492
J Clin Immunol. 2005 Nov;25(6):541-50
pubmed: 16380818
J Immunol Methods. 1991 Jun 3;139(2):271-9
pubmed: 1710634
J Oleo Sci. 2007;56(12):615-21
pubmed: 17992001
Diabetes Obes Metab. 2010 Jan;12(1):72-81
pubmed: 19840063
Thyroid Res. 2011 Oct 05;4:14
pubmed: 21975053
Mar Drugs. 2015 Aug 04;13(8):4799-813
pubmed: 26248075
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Ann Oncol. 2017 Aug 1;28(8):1788-1802
pubmed: 28407090
Nutr Cancer. 2017 Aug-Sep;69(6):855-861
pubmed: 28718722
Nutr Cancer. 2017 Oct;69(7):1043-1052
pubmed: 28990814
Apoptosis. 2017 Dec;22(12):1487-1509
pubmed: 29067538
Anticancer Res. 2018 Apr;38(4):2169-2179
pubmed: 29599336
Oncol Rep. 2018 Jul;40(1):414-424
pubmed: 29693702
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9090-5
pubmed: 8799159
Mol Pharmacol. 1997 Sep;52(3):465-72
pubmed: 9281609

Auteurs

Shuya Tamura (S)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.
2Graduate School of Food and Nutritional Sciences, Toyo University, 1-1-1 Izumino, Itakura, Oura, Gunma, 374-0193 Japan.

Takumi Narita (T)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Gen Fujii (G)

3Central Radioisotope Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Shingo Miyamoto (S)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.
4Department of Cancer Cell Research, Sasaki Institute, Sasaki Foundation, 2-2, Kandasurugadai Chiyoda-ku, Tokyo, 101-0062 Japan.

Takahiro Hamoya (T)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Yurie Kurokawa (Y)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Maiko Takahashi (M)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Kouhei Miki (K)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Yui Matsuzawa (Y)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Masami Komiya (M)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Masaru Terasaki (M)

6School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 1757 Kanazawa, Ishikari-Tobetsu, Hokkaido 061-0293 Japan.

Tomohiro Yano (T)

2Graduate School of Food and Nutritional Sciences, Toyo University, 1-1-1 Izumino, Itakura, Oura, Gunma, 374-0193 Japan.

Michihiro Mutoh (M)

1Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.
5Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan.

Classifications MeSH